Aspirin after myocardial infarction
暂无分享,去创建一个
[1] J. Stamler. Aspirin in coronary heart disease , 1980 .
[2] Lippincott Williams Wilkins,et al. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.
[3] K. Uberla,et al. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. , 1980, Haemostasis.
[4] P. Elwood,et al. ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.
[5] R. Abbate,et al. DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN , 1979, The Lancet.
[6] G. Verbruggen,et al. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration. , 1979, The Journal of rheumatology.
[7] R. Peto,et al. Clinical trial methodology , 1978, Nature.
[8] M. Mardiney,et al. Alteration of cellular ribonucleases associated with murine oncogenic virus infection. , 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[9] P C Elwood,et al. A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.
[10] G. Levy,et al. Effect of pharmaceutical formulation on gastrointestinal bleeding from aspirin tablets. , 1972, Archives of internal medicine.